🇺🇸 FDA

Company profile · Sponsor

TuHURA

TuHURA Biosciences, Inc./NV

HURA · NYSE pharma TAMPA, FL, USA
Pipeline
4
Drugs
0
Patents
0

Quick answer

TuHURA (HURA) is a pharma company. headquartered in TAMPA, FL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker HURA
Exchange NYSE
Company type pharma
Headquarters TAMPA, FL, USA
SEC CIK 0001498382

Pipeline (4)

Search pipeline →

  1. IFx-Hu2.0

    TuHURA

    Advanced Or Metastatic Merkel Cell Carcinoma

    phase 3 small molecule active

    2 trials

  2. IFx-Hu2.0

    TuHURA

    Cutaneous Melanoma, Stage III

    phase 1 mab completed

    1 trial

  3. IFx-Hu2.0

    TuHURA

    Cutaneous Squamous Cell Carcinoma

    phase 1 mab completed

    1 trial

  4. IFx-Hu2.0

    TuHURA

    Merkel Cell Carcinoma

    phase 1 mab completed

    1 trial

Frequently asked questions

What is TuHURA?

TuHURA (HURA) is a pharma company. headquartered in TAMPA, FL, USA. listed on NYSE. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does TuHURA sponsor?

We track 4 ClinicalTrials.gov-linked programs for TuHURA, including IFx-Hu2.0 and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does TuHURA company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.